Research progress on siRNA delivery with nonviral carriers.
about
High-density lipoproteins for the systemic delivery of short interfering RNA.Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophagesCo-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer.Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticles.Design and Experimental Evolution of trans-Splicing Group I Intron Ribozymes.EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism.Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.Computational prediction of efficient splice sites for trans-splicing ribozymes.Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 CellsDifferential baseline expression and angiotensin II-stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive ratsNonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.Sendai F/HN viroplexes for efficient transfection of leukemic T cells.Magnetic targeting strategies in gene delivery.In vivo gene delivery by nonviral vectors: overcoming hurdles?Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.Therapeutic siRNA: principles, challenges, and strategies.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Dendrimers for siRNA Delivery.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Functional nanostructures for effective delivery of small interfering RNA therapeutics.Synthesis and Excellent Duplex Stability of Oligonucleotides Containing 2'-Amino-LNA Functionalized with Galactose Units.Peptide-LNA oligonucleotide conjugates.Cationic cell-penetrating peptides as vehicles for siRNA delivery.Nano-ART and NeuroAIDS.Ternary polymeric nanoparticles for oral siRNA delivery.ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model.Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.High efficiency, site-specific transfection of adherent cells with siRNA using microelectrode arrays (MEA).Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.Efficient siRNA transfection to the inner ear through the intact round window by a novel proteidic delivery technology in the chinchilla.Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy.Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes.Glioma targeting peptide modified apoferritin nanocage.RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities
P2860
Q33786171-6F53694F-3C17-442F-94B0-6BBAF3BAE7F7Q34082638-C2906AE9-AA3F-4EC6-9BAF-7960295FFC7DQ34502283-A7B031C8-9099-4E1E-94C9-D87C64458C13Q34655168-46960C52-C7FC-4DB5-A824-394A0230910AQ34680414-26A6E728-0F50-4EC6-9EA8-D8328201E9F3Q35018628-33EDF6AF-77BB-4D23-9563-5B165C30CB4FQ35153708-BBE4C07E-0DCF-48A2-95D6-95ACE6AFF0CEQ35547238-1061FC08-76F7-4949-8C09-1F6AFEA1F888Q35576275-C5AC3284-F82B-43EB-BB6A-59A73AA25F77Q35630481-38BC1982-B475-4048-8305-AEF539CC811AQ35775827-54D9C969-C54A-4023-9014-0BBDC20594B9Q35831738-0CAEC78B-B6EF-4C5C-A435-44C54CEEE014Q36071406-8CD36D2E-3245-464C-B1F1-ACA4ECB3157CQ36456015-0CF41B9B-26BE-40CD-A12D-E2B1F76BF3D4Q36460478-EAB995E4-E64F-49F0-8AD7-0699F8B88070Q37053575-A90E2DD6-EEFC-40D6-8FB3-C6EA616FA548Q37094610-F59A3299-80D3-4AFB-8278-62BF0EBAA017Q37955213-0623CF31-1679-4796-9D5E-B486BC2D583FQ38004708-6FD70306-8352-46C1-888C-DCEEC0F46F14Q38015511-531B05A5-BCC6-4EBB-8AD8-51680FB0D56BQ38021996-AD6D418B-1365-409A-8505-65BA9AC340B8Q38037048-6F70CDD4-8D21-4075-9B55-9D779DF80267Q38166200-A26879C6-34F4-49E7-8818-FCA2B5DCBAA0Q38217461-6B43873B-40F4-4DF5-80A2-F2D1E85CEFA9Q38256970-EB6EF188-F4D6-4330-A87A-3B11DF2AE1A0Q38288070-8152E63A-26AB-484B-B3ED-DC2698B0A6EDQ38315418-6E11FE95-7BD7-49B7-A0C4-5D499EA39F58Q38495028-A1EB442E-F744-4B7A-857B-8A8CF80245A5Q38823456-7A4BCE25-FF89-40D9-8127-F4A1EAAD5B1DQ39212602-B61A0F06-3EFD-44F8-B935-9E406C581BA6Q39454868-4C867F4D-3758-4C67-AE67-269E139F8820Q41372707-FDB70A25-DE4C-4523-817B-6774DB0ABCBBQ41461937-03C4B0C0-E125-4A45-95EA-27D279468D6AQ41843445-FF542002-5D8B-4A9A-B60E-E1F01C55E2DCQ41845496-99CFDD67-26D2-46D8-81C9-E00DC876CD7BQ45855846-CDEAE900-7008-481B-9612-3C76A5E4DE9EQ47967656-E55E3BDD-EF6E-44D4-A2D0-7AD434924619Q50443615-BC070383-0E96-40FB-8E47-9D8387754099Q55457197-20F7EAFF-FB4C-4632-98DC-C5F0365E4E5BQ56192358-ABC4D280-731E-45C2-95EE-CBE504082C43
P2860
Research progress on siRNA delivery with nonviral carriers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Research progress on siRNA delivery with nonviral carriers.
@en
Research progress on siRNA delivery with nonviral carriers.
@nl
type
label
Research progress on siRNA delivery with nonviral carriers.
@en
Research progress on siRNA delivery with nonviral carriers.
@nl
prefLabel
Research progress on siRNA delivery with nonviral carriers.
@en
Research progress on siRNA delivery with nonviral carriers.
@nl
P2093
P2860
P356
P1476
Research progress on siRNA delivery with nonviral carriers.
@en
P2093
Xiao-Rong Li
Xin-Ling Liu
P2860
P304
P356
10.2147/IJN.S17040
P407
P577
2011-05-11T00:00:00Z